BLU2864
BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
452.43
Molecular Formula
C24H19F3N4O2
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
2810747-89-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1014583-01 0.02 mg (E-Coli)
Recombinant Burkholderia cenocepacia Xylose isomerase (xylA)
Ask
View Details MBS1014583-02 0.02 mg (Yeast)
Recombinant Burkholderia cenocepacia Xylose isomerase (xylA)
Ask
View Details